Characterization and hydration kinetics of tricalcium silicate cement for use as a dental biomaterial

Torabinejad M, White DJ. Tooth filling material and use. US Patent Number: 5,769,638. 1995.

Camilleri, 2005, The constitution of mineral trioxide aggregate, Dent Mater, 21, 297, 10.1016/j.dental.2004.05.010

Camilleri, 2007, Hydration mechanisms of mineral trioxide aggregate, Int Endod J, 40, 462, 10.1111/j.1365-2591.2007.01248.x

Camilleri, 2008, Characterization of hydration products of mineral trioxide aggregate, Int Endod J, 41, 408, 10.1111/j.1365-2591.2007.01370.x

Camilleri, 2005, The chemical constitution and biocompatibility of accelerated Portland cement for endodontic use, Int Endod J, 38, 834, 10.1111/j.1365-2591.2005.01028.x

Estrela, 2000, Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal, Braz Dent J, 11, 3

Funteas, 2003, A comparative analysis of mineral trioxide aggregate and Portland cement, Aust Endod J, 29, 43, 10.1111/j.1747-4477.2003.tb00498.x

Asgary, 2004, A comparative study of white mineral trioxide aggregate and white Portland cements using X-ray microanalysis, Aust Endod J, 30, 89, 10.1111/j.1747-4477.2004.tb00416.x

Oliveira, 2007, Comparative chemical study of MTA and Portland cements, Braz Dent J, 18, 3, 10.1590/S0103-64402007000100002

Neville, 1981

Achternbosch, 2003

Dentsply data sheet: Just the facts. ProRoot MTA Root Canal Repair Material vs. Portland cement. www.dentsply.co.uk.

Primus, 2006, Comments on “Arsenic release provided by MTA and Portland cement” by Duarte MA, et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, 416, 10.1016/j.tripleo.2005.09.023

Chang, 2010, Analysis of heavy metal contents in gray and white MTA and 2 kinds of Portland cement: a preliminary study, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, 642, 10.1016/j.tripleo.2009.12.017

Monteiro Bramante, 2008, Presence of arsenic in different types of MTA and white and gray Portland cement, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 106, 909, 10.1016/j.tripleo.2008.07.018

Duarte, 2005, Arsenic release provided by MTA and Portland cement, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 99, 648, 10.1016/j.tripleo.2004.09.015

Schembri, 2010, Analysis of heavy metals in mineral trioxide aggregate and Portland cement, J Endod, 36, 1210, 10.1016/j.joen.2010.02.011

British Standard Institution Dentistry – Water-based cements. Part 1: Powder/liquid acid–base cements. ISO EN 9917-1; 2007.

De-Deus, 2009, Negligible expression of arsenic in some commercially available brands of Portland cement and mineral trioxide aggregate, J Endod, 35, 887, 10.1016/j.joen.2009.03.003

Matsunaga, 2010, Analysis of arsenic in gray and white mineral trioxide aggregates by using atomic absorption spectrometry, J Endod, 36, 1988, 10.1016/j.joen.2010.08.045

Gonçalves, 2010, Evaluation of physico-chemical properties of Portland cements and MTA, Braz Oral Res, 24, 277, 10.1590/S1806-83242010000300004

Huan, 2008, Study on physicochemical properties and in vitro bioactivity of tricalcium silicate-calcium carbonate composite bone cement, J Mater Sci Mater Med, 19, 2913, 10.1007/s10856-008-3423-4

Zhao, 2008, Self-setting properties and in vitro bioactivity of Ca3SiO5/CaSO4.1/2H2O composite cement, J Biomed Mater Res, 85, 336, 10.1002/jbm.a.31523

Huan, 2007, Novel tricalcium silicate/monocalcium phosphate monohydrate composite bone cement, J Biomed Mater Res B Appl Biomater, 82, 352, 10.1002/jbm.b.30740

Zhao, 2005, The self-setting properties and in vitro bioactivity of tricalcium silicate, Biomaterials, 26, 6113, 10.1016/j.biomaterials.2005.04.025

Ridi, 2005, Hydration process of cement in the presence of a cellulosic additive A calorimetric investigation, J Phys Chem B, 109, 14727, 10.1021/jp050237n

Laurent, 2008, Induction of specific cell responses to a Ca(3)SiO(5)-based posterior restorative material, Dent Mater, 24, 1486, 10.1016/j.dental.2008.02.020

Wang, 2008, Characterization of Ca3SiO5/CaCl2 composite cement for dental application, Dent Mater, 24, 74, 10.1016/j.dental.2007.02.006

Ding, 2009, Novel fast-setting calcium silicate bone cements with high bioactivity and enhanced osteogenesis in vitro, J Mater Chem, 19, 1183, 10.1039/b819033j

Forbes, 1998, Risk factors, causality, and policy initiatives: the case of aluminum and mental impairment, Exp Gerontol, 33, 141, 10.1016/S0531-5565(97)00061-2

Chen, 2009, Physicochemical properties of calcium silicate cements for endodontic treatment, J Endod, 35, 1299, 10.1016/j.joen.2009.05.036

Scrivener, 1993, Delayed ettringite formation: a microstructural and microanalytical study, Adv Cem Res, 20, 139, 10.1680/adcr.1993.5.20.139

Sarkar, 2005, Physicochemical basis of the biologic properties of mineral trioxide aggregate, J Endod, 31, 97, 10.1097/01.DON.0000133155.04468.41

Reyes-Carmona, 2009, Biomineralization ability and interaction of mineral trioxide aggregate and white Portland cement with dentin in a phosphate-containing fluid, J Endod, 35, 731, 10.1016/j.joen.2009.02.011

Coleman, 2007, A preliminary investigation of the in vitro bioactivity of white Portland cement, Cem Concrete Res, 37, 1518, 10.1016/j.cemconres.2007.08.008

Torabinejad, 1995, Investigation of mineral trioxide aggregate for root-end filling in dogs, J Endod, 21, 603, 10.1016/S0099-2399(06)81112-X

Torabinejad, 1997, Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys, J Endod, 23, 225, 10.1016/S0099-2399(97)80051-9

Taylor, 1997

Camilleri, 2011, Evaluation of the effect of intrinsic material properties and ambient conditions on the dimensional stability of white mineral trioxide aggregate and Portland cement, J Endod, 37, 239, 10.1016/j.joen.2010.11.012

Chen, 2009, In vitro bioactivity and biocompatibility of dicalcium silicate cements for endodontic use, J Endod, 35, 1554, 10.1016/j.joen.2009.08.006